Official registry condition

Healthy Subjects peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Healthy Subjects. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

2 profiles.

Registry update years

2017–2024 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases1

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 1 selected PubMed records and 0 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Healthy Subjects unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT03279302

PeptideScanner retained ClinicalTrials.gov record NCT03279302 at 2026-11-16T01:46:56.290Z. Its registry update date was 2017-12-22, and PeptideScanner's reviewed identity mapping was glepaglutide.

PeptideScanner change date
November 16, 2026
Cited source date
December 22, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05995704

PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 24, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06002555

PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 26, 2024
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →